Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0716 USD | -4.60% | -9.94% | -74.43% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Health and Wealth Supplements
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ian Parker
CEO | Chief Executive Officer | - | - |
Michael Berg
CHM | Chairman | - | - |
John Lee
DFI | Director of Finance/CFO | - | - |
Richard Alloway
IRO | Public Communications Contact | - | 22-12-31 |
Diane Koontz
PRN | Corporate Officer/Principal | - | 22-10-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Parker
CEO | Chief Executive Officer | - | - |
Director/Board Member | - | 22-01-10 | |
John Lee
DFI | Director of Finance/CFO | - | - |
Michael Berg
CHM | Chairman | - | - |
Robert McGrath
BRD | Director/Board Member | - | - |
Denver Riggleman
BRD | Director/Board Member | - | - |
Fig Annunziato
BRD | Director/Board Member | - | 22-06-13 |
Dong Yun Kim
BRD | Director/Board Member | - | 22-06-13 |
Company contact information
1st Jan change | Capi. | |
---|---|---|
-74.43% | 50.95M | |
+12.53% | 3,151B | |
+11.73% | 90.11B | |
+8.73% | 81.27B | |
-14.86% | 53.72B | |
+38.50% | 51.13B | |
+35.47% | 47.65B | |
-31.35% | 41.1B | |
+77.68% | 40.85B | |
+3.63% | 28.7B |
- Stock Market
- Equities
- EMOR Stock
- Company Healixa Inc.